Why Pro-Dex, Inc.’s (PDEX) Stock Is Up 6.41%
As of Wednesday, September 16, Pro-Dex, Inc.’s PDEX share price has surged by 6.41%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Commentary & Analysis
Why Pro-Dex, Inc.’s (PDEX) Stock Is Down 9.37%
As of Wednesday, September 09, Pro-Dex, Inc.’s PDEX share price has dipped by 9.37%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Pro-Dex, Inc.’s (PDEX) Stock Is Down 10.77%
As of Wednesday, September 09, Pro-Dex, Inc.’s PDEX share price has dipped by 10.77%, which has investors questioning if this is right time to buy.Tudor Pop
Why Pro-Dex, Inc.’s (PDEX) Stock Is Down 5.39%
As of Tuesday, September 08, Pro-Dex, Inc.’s PDEX share price has dipped by 5.39%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Pro-Dex, Inc.’s (PDEX) Stock Is Up 24.28%
As of Friday, September 04, Pro-Dex, Inc.’s PDEX share price has surged by 24.28%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $191.6 | $376.8 | 28% |
|
| Shares Out (Mil) | 3.3 | 40.7 | 11% |
|
| Institutional Ownership | 59.4% | 83.2% | 38% |
|
| Float (Mil) | 1.5 | 35.1 | 4% |
|
| Beta | 0.06 | 0.85 | 7% |
|
| Avg Daily Volume (000s) | 49 | 314 | 28% |
|
| Price Change (52-week) |
125.6% | 61.6% | 96% |
|
| Growth | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.3% | 11.8% | 74% |
|
| Net Income (5yr) | 17.2% | (5.5%) | 68% |
|
| EPS (5yr) | 21.3% | 10.4% | 71 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 40.1% | (15.5%) | 91% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.670 | $3.090 | $3.360 | |
| Month Ago EPS | $0.670 | $3.090 | $3.360 | |
| # Rev Up | 1 | 1 | na | |
| # Rev Down | 0 | 0 | na | |
| Three Months Ago EPS | $0.660 | $2.780 | na | |
| Year/Year Chg | (23.1%) | (25.0%) | na | |
| Financials | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $78 | $128 | 24% |
|
| Net Income (TTM) (Mil) | $14 | ($9) | 47% |
|
| EPS (TTM) | $4.235 | ($0.400) | 84% |
|
| Operating Cash Flow (TTM) (Mil) | $7 | ($2) | 37% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $1 | 55% |
|
| Long-Term Debt (Q1) (Mil) | $14 | $26 | 30% |
|
| Enterprise Value (Q1) (Mil) | $244 | $409 | 28% |
|
| Valuation | PDEX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.00 | 2.49 | 75% |
|
| P/E | 14.5 | 25.3 | 38% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.7 | 1.5 | 35% |
|
| Ratios | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 31.4% | 59.0% | 37% |
|
| Net Margin | 17.6% | (6.9%) | 76% |
|
| ROA | 20.1% | (12.2%) | 96% |
|
| ROE | 32.4% | (10.7%) | 88% |
|
| Liabilities to Assets | 36.1% | 47.2% | 27% |
|
| F-Score | 6 | 4 | 67% |
|
Passing Stock Screens
As of 10/14/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Buffettology: EPS Growth
Factors: Quality, Growth
Buffett approach seeking consumer monopolies selling at a reasonable price.
| Performance Since Inception: | 12.2% |
| +/- S&P 500: | +4.7 |
FACTOR STRATEGY
Return on Equity Screen
Factors: Quality, Growth
A screen that identifies stocks with above average earnings and sales growth that have consistently outperformed their peers measured by ROE.
| Performance Since Inception: | 12.7% |
| +/- S&P 500: | +5.2 |
FACTOR STRATEGY
Value on the Move--PEG With Hist Growth Screen
Factors: Value, Quality, Momentum, Growth
Using PEG ratios and price strength to find growth stocks trading at a reasonable price.
| Performance Since Inception: | 13.6% |
| +/- S&P 500: | +6.1 |
GURU STRATEGY
Buffettology: Sustainable Growth Screen
Factors: Quality, Growth
Buffett approach seeking consumer monopolies selling at a reasonable price.
| Performance Since Inception: | 13.0% |
| +/- S&P 500: | +5.5 |
GURU STRATEGY
Zweig Screen
Factors: Value, Quality, Growth
A strategy that seeks to identify companies with strong growth, a reasonable price-earnings ratio and strong price action.
| Performance Since Inception: | 11.3% |
| +/- S&P 500: | +3.8 |
